<?xml version="1.0" encoding="UTF-8"?>
<p>At baseline, the mean (SD) percentage of days abstinent in the past 30 days was 40% (1.6%), with no significant differences across arms (
 <xref rid="zoi200622t2" ref-type="table">Table 2</xref>). At the 3-month visit, the proportion increased to a mean (SE) of 61% (3.1%) in the combined intervention group, 67% (2.9%) in the brief intervention group, and 44% (3.2%) in the SOC group (
 <xref rid="zoi200622t2" ref-type="table">Table 2</xref>) (Cohen 
 <italic>d</italic> for difference for combined intervention vs SOC: 46%; 95% CI, 22% to 70%; for brief intervention vs SOC: 64%; 95% CI, 40% to 88%; for combined intervention vs brief intervention: –18%; 95% CI, –41% to 6%) (eTable 3 in 
 <xref ref-type="supplementary-material" rid="note-ZOI200622-1-s">Supplement 2</xref>). This difference was sustained through the 12-month visit, at which the mean (SE) percentage of days abstinent was 65% (3.1%) in the combined intervention group and 65% (3.2%) in the brief intervention group compared with 50% (3.4%) in the SOC group (
 <xref rid="zoi200622t2" ref-type="table">Table 2</xref>) (Cohen 
 <italic>d</italic> for difference for combined intervention vs SOC and brief intervention vs SOC: 39%; 95% CI, 15% to 64%; for combined intervention vs brief intervention: 0%; 95% CI, –24% to 24%) (eTable 3 in 
 <xref ref-type="supplementary-material" rid="note-ZOI200622-1-s">Supplement 2</xref>).
</p>
